Director, Global HEOR
Description
Cornerstone Search Group’s HEOR/Market Access Practice is pleased to have been retained by a leading Boston-area pharmaceutical company renowned for operating at the forefront of scientific innovation, successfully launching multiple breakthrough medicines, and having top-notch talent. They are seeking a high EQ HEOR professional for a newly-created critical global HEOR leadership position with direct reports that will define and implement the global HEOR strategies for the anticipated US and global launches of a high-profile, “game-changing,” first-in-class asset projected to be a multi-blockbuster. The HEOR team works cross-functionally and across regions to envision, create, and communicate HEOR evidence (including a particular focus on COA / PRO for this program) to support the value of this and future follow-up assets for reimbursement and healthcare payers across all stages of the product lifecycle.
COMPENSATION: Competitive base salary and annual bonus with generous LTI program and strong benefits.
Location
LOCATION: Boston Metro Area (on-site or hybrid). Three days/week on-site is required.
RELOCATION: Full relocation assistance is available.
Features
4 HIGHLY ATTRACTIVE FEATURES:
- High-Profile Impact: This is a critical global HEOR leadership role, as your team’s strategy and output will be a major determining factor on whether this first-in-class asset will have its anticipated societal impact.
- Stable and Growing Company: In an era of instability and staff cutbacks by companies both small and large, our client’s scientific and strategic acumen has led to continued growth, which has provided both organizational stability and demonstrated career progression (including for this hiring manager).
- Strong HEOR Leadership: Our client’s HEOR department has steady, proven, high EQ leadership.
- Attractive to Senior Directors: With direct reports, a highly competitive compensation program, a sterling reputation, and a demonstrated history of internal career growth, this position can be attractive to very experienced HEOR professionals.
Responsibilities
RESPONSIBILITIES IN A NUTSHELL:
- Lead and execute US/Global HEOR and COA/PRO strategies
- People management
- Serve as the HEOR lead on cross-functional teams to ensure that global HEOR strategic plans reflect the input of key stakeholders and are aligned with commercial, clinical, medical, RWE, and market access plans
- Oversee evidence generation, including CEAS and BIMs, prospective and retrospective observational studies, ITCs, meta-analyses, systematic reviews, PRO measure development and validation, and other research as needed to support the asset value.
- Expedite market access with optimal pricing globally by supporting local model adaptations and HTA submissions to ensure accurate, consistent, and effective use of HEOR evidence.
Qualifications / Requirements
DESIRED SKILLS / QUALIFICATIONS / EXPERIENCES / BEHAVIORS:
- MA/MS, MPH, PharmD, PhD, or MD
- 7+ years of relevant experience in health economics, outcomes research, PRO / COA, or a directly related field.
- Prior supervisory or management experience is a plus, but candidates with demonstrated leadership capabilities will also be considered.
- Experience leading cross-functional teams.
- Global experience (e.g., HTA submission).
- Our client is open to therapeutic areas of experience.
- High emotional intelligence ( EQ ) coupled with strong communication, presentation, and influencing skills across internal and external stakeholders.
Recently Completed Retained Searches by Cornerstone
REPRESENTATIVE RETAINED SEARCH ASSIGNMENTS:- CEO | specialty pharma start-up
- CEO | regenerative medicine start-up
- US CEO | established European small pharma
- President/US Commercial Head | Generics Pharma
- CMO | late-stage public biotech
- CMO | mid-size pharma
- CSO | mid-size global biotech
- SVP, Head of Global Medical Affairs | mid-size oncology company
- SVP, Head of Global Clinical Development | multi-TA mid-size pharma
- SVP, Head of Global Regulatory Affairs | late-stage Israeli biotech
- Global Head, Oncology R&D | mid-size European pharma
- Group VP, Global Commercial Head | API Business Unit | Indian pharma
- VP, Data Science RWE | Top 5 Pharma
- VP, Head of Regulatory Affairs | Boston Biotech
- VP, US Head of Regulatory Affairs | Top 20 Pharma
- VP, Head of R&D Operations | Boston biotech
- VP, Head of HEOR (Health Economics & Outcomes Research | Top CNS specialty pharma
- VP, Head of US HEOR & RWE | Top 5 Pharma
- VP, Head of Real-World Evidence | Top 5 pharma
- VP, Head of US HEOR | Top Oncology Pharma
- ED, Head of HEOR | Top West Coast Pharma
- VP, Head of Global Market Access | Top Oncology Specialty Pharma
- VP, Head of US Market Access | High-profile late stage biotech
- VP, Head of US Market Access | West Coast Late-Stage Public Biotech
- VP, Head of Heme/Onc Clinical Research | Public oncology biotech
- VP, Head of Clinical Development | late-stage anti-infectives UK pharma
- VP, Head of Global Drug Safety & PV | Chinese oncology biotech
- ED, Head of Clinical Operations | British VC-backed biotech
- ED, Global Commercial Strategy Franchise Head | Top rare disease Boston pharma
- ED, Head of Global Clinical Pharmacology | Public oncology biotech
- ED, Head of Global HEOR | Large US Pharma
- Head, Patient Advocacy | European commercial-stage rare disease biotech
- Medical Directors (Director/SD/ED levels) in Translational Medicine / Clinical Development / Medical Affairs / Drug Safety: 75+ retained assignments
- HEOR/RWE/Market Access (AD/Director/SD/ED levels): 100+ retained assignments
Cornerstone's Privacy Policy
Cornerstone Search Group considers all inquiries, resume submissions, and any other personal information submitted to us as confidential information. This information will not be shared with any parties outside of Cornerstone Search Group without your prior permission.